Search - tctmd.com

Displaying 1 - 20 of 191

Sort: Relevancy | Date

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Daily News

STAR Trial Gives Insight Into Two-Stage CTO PCI in Complex Patients

Yael L. Maxwell

December 05, 2025

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

JSousa1.cropped (002) in memoriam_header

News Daily News

Stent Pioneer José Eduardo Sousa Dies, Age 88

Shelley Wood

March 14, 2022

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Daily News

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case

Yael L. Maxwell

March 03, 2021

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

News Daily News

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

L.A. McKeown

March 09, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

Caitlin E. Cox

July 11, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Michael O'Riordan

February 22, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Daily News

Ultrathin-Strut DES Outperform Second-Gen DES at 1 Year: Meta-analysis

Caitlin E. Cox

June 28, 2018

News Daily News

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

L.A. McKeown

February 08, 2017

News Daily News

After EXCEL and NOBLE, New Meta-analysis Revisits PCI vs Surgery for Unprotected Left Main CAD

Michael O'Riordan

December 14, 2016

Advertisement

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

STAR Trial Gives Insight Into Two-Stage CTO PCI in Complex Patients

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Top Endovascular News of 2024

Top Endovascular News of 2022

Stent Pioneer José Eduardo Sousa Dies, Age 88

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

EVOLVE Short DAPT in Print: P2Y12 Decisions Can Safely Be Made Case-by-Case

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms

TCTMD’s Top 10 Most Popular Stories for February 2019

FDA Approves Orsiro Ultrathin-Strut Stent for CAD

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Ultrathin-Strut DES Outperform Second-Gen DES at 1 Year: Meta-analysis

10-Year Follow-up of Early DES Shows Steady Risk of Late Events

After EXCEL and NOBLE, New Meta-analysis Revisits PCI vs Surgery for Unprotected Left Main CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content